>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • UPWK +23%, TH +22.4%, EVGO +18.3%, YOU +17.5%, ENVX +14.7% (also its IoT & Wearable cells outperformed competitive cells), EOLS +13.6%, PETQ +12.6%, LZ +12.2%, KD +11.1%, JHX +10.8%, AVDX +9.1%, ODD +8.4%, RIVN +8.2% (also increases FY23 production guidance), FNA +7.2%, DVA +6.9%, AGTI +6.4%, TBLA +6.3%, LITE +6.3%, IPAR +5.9%, MQ +5.6%, ODP +5.4%, CARG +5.3% (also authorizes new $250 mln share repurchase program; also to acquire remaining minority interest in CarOffer for $75 mln), BBAI +5.1% (also to acquire Pangiam for $70 mln), ANIP +5.1%, VCYT +5% (also enters into a multi-year agreement with ILMN), MNKD +5%, PRIM +5%, KRNT +5%, FSM +4.8%, AKAM +4.5%, PWSC +4.3%, AGO +4.2% (also names new CFO and COO), BEKE +4%, ADNT +3.9%, DNLI +3.6%, JRVR +3.5%, INGN +3.4%, NYT +3.3%, BROS +3.1%, MRC +3.1%, ICL +3.1%, WRBY +2.9%, AXON +2.7%, PAYO +2.6%, RPRX +2.5%, CRL +2.4%, TEVA +2.3%, EXR +2.2%, CAVA +2.1%, BHF +2.1%, ZLAB +1.9%, GPRO +1.9%, GMED +1.8%, CCO +1.8%, MIDD +1.5%, WTI +1.3%, HLMN +1.3%, TKO +1.2% (also The CW Network to become the exclusive broadcast home to WWE NXT), FLNG +1.2%, UAA +1.2%, APLE +1.1%, GXO +1.1%, REYN +1.1%
Other news:
  • AMR +6.5% (to join S&P SmallCap 600)
  • BTAI +6.4% (reports positive overall survival results from single-arm open-label Phase 2 Trial of BXCL701 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) of adenocarcinoma phenotype)
  • AJG +5.9% (to acquire The Evans Agency)
  • BALY +3.8% (several insider purchases disclosed)
  • AMBC +3.4% (hires external advisors to discuss options for Ambac Assurance)
  • AMEH +2.6% (to acquire assets relating to Community Family Care)
  • FG +2.4% (increases dividend)
  • ATPC +2.4% (forges ahead with sustainable energy business)
  • WISH +1.9% (to explore strategic alternatives also reports earnings)
Analyst comments:
  • MQ +7.5% (initiated with a Positive at Susquehanna; tgt $9)
  • FLNC +5.3% (upgraded to Buy from Neutral at BofA Securities)
  • MCHP +2.2% (upgraded to Buy from Neutral at Citigroup)